Radiation
Radiation Therapy for Breast Cancer
Recruiting1 award13 criteria
Hamilton
This trial is testing whether adding a tumour bed boost after breast conserving surgery (BCS) in women with non-low risk ductal carcinoma in situ (DCIS) reduces the risk of local recurrence. There are two fractionation arms in this trial: a shorter fractionation arm and a standard fractionation arm. The overall objectives of the trial are to improve the outcome of women with non-low risk DCIS treated with BCS and to individualize treatment selection for women with DCIS to achieve long term disease control with minimal toxicity.
Janus Kinase (JAK) Inhibitor
Ruxolitinib for Precancerous Breast Conditions
Recruiting0 awardsPhase 2
Birmingham, Alabama
This trial is testing if ruxolitinib can change early abnormal breast cells that might turn into cancer. Some participants will take the drug for a short period, while others will not. Afterward, all participants will have surgery to remove the abnormal cells. Ruxolitinib has been evaluated in various clinical trials for treating certain types of breast cancer.
Procedure
Surgery vs Active Monitoring for Low-Risk Ductal Carcinoma In Situ
Recruiting1 award
Anchorage, Alaska
This trial compares regular check-ups to surgery for women with low-risk Ductal Carcinoma in Situ (DCIS). The goal is to see if monitoring the condition without immediate surgery can provide similar outcomes in terms of cancer control and quality of life. Surgery can lead to persistent pain and other issues, so avoiding it might benefit patients. The study is examining the safety of monitoring low-risk DCIS without surgery.
Hormone Therapy
Telephone Support for Breast Cancer Treatment Adherence
Recruiting1 award8 criteria
Goldsboro, North Carolina
This trial studies a telephone intervention to see if it increases adherence to adjuvant hormonal therapy in patients with breast cancer. The intervention may help to increase doctor-patient communication and patients' adherence to their prescribed medication.
Popular Filters
Trials for DCIS Patients
Cancer Vaccine
MUC1 Vaccine + Aromatase Inhibitor for Breast Cancer
Recruiting1 awardPhase 1
Pittsburgh, Pennsylvania
This trial is enrolling post-menopausal women with a condition called DCIS. There are two groups in the trial. One group will receive a medication called an aromatase inhibitor for about
Hormone Therapy
Hormonal Therapy for Early-Stage Breast Cancer
Recruiting1 awardPhase 2
Winston-Salem, North Carolina
This trial is testing if hormonal therapy & monitoring can manage early-stage breast cancer effectively. Participants get treatment & MRI exams, plus provide samples to study immune & genetic factors.
Cancer Vaccine
H2NVAC Vaccine for Breast Cancer
Recruiting1 awardPhase 1
Jacksonville, Florida
This trial studies the H2NVAC vaccine, which aims to boost the immune system to fight breast cancer in patients with HER2-expressing DCIS. The vaccine helps the body recognize and attack cancer cells by targeting the HER2 protein. H2NVAC is a vaccine targeting the HER2 protein, similar to other HER2/neu vaccines being tested for their ability to elicit immune responses against breast cancer.
Trials for Ductal Carcinoma Patients
Cancer Vaccine
MUC1 Vaccine + Aromatase Inhibitor for Breast Cancer
Recruiting1 awardPhase 1
Pittsburgh, Pennsylvania
This trial is enrolling post-menopausal women with a condition called DCIS. There are two groups in the trial. One group will receive a medication called an aromatase inhibitor for about
Hormone Therapy
Hormonal Therapy for Early-Stage Breast Cancer
Recruiting1 awardPhase 2
Winston-Salem, North Carolina
This trial is testing if hormonal therapy & monitoring can manage early-stage breast cancer effectively. Participants get treatment & MRI exams, plus provide samples to study immune & genetic factors.
Trials for ER Positive Patients
Cancer Vaccine
MUC1 Vaccine + Aromatase Inhibitor for Breast Cancer
Recruiting1 awardPhase 1
Pittsburgh, Pennsylvania
This trial is enrolling post-menopausal women with a condition called DCIS. There are two groups in the trial. One group will receive a medication called an aromatase inhibitor for about
Hormone Therapy
Hormonal Therapy for Early-Stage Breast Cancer
Recruiting1 awardPhase 2
Winston-Salem, North Carolina
This trial is testing if hormonal therapy & monitoring can manage early-stage breast cancer effectively. Participants get treatment & MRI exams, plus provide samples to study immune & genetic factors.
Radiation
Partial Breast Irradiation for Early Stage Breast Cancer
Recruiting1 awardPhase 2 & 3
Jacksonville, Florida
This trial looks at how well a shorter, higher-dose radiation therapy works to treat early stage breast cancer. The cancer is only in the breast, and this treatment may have fewer side effects.
Trials With No Placebo
Cancer Vaccine
MUC1 Vaccine + Aromatase Inhibitor for Breast Cancer
Recruiting1 awardPhase 1
Pittsburgh, Pennsylvania
This trial is enrolling post-menopausal women with a condition called DCIS. There are two groups in the trial. One group will receive a medication called an aromatase inhibitor for about
Hormone Therapy
Hormonal Therapy for Early-Stage Breast Cancer
Recruiting1 awardPhase 2
Winston-Salem, North Carolina
This trial is testing if hormonal therapy & monitoring can manage early-stage breast cancer effectively. Participants get treatment & MRI exams, plus provide samples to study immune & genetic factors.
Cancer Vaccine
H2NVAC Vaccine for Breast Cancer
Recruiting1 awardPhase 1
Jacksonville, Florida
This trial studies the H2NVAC vaccine, which aims to boost the immune system to fight breast cancer in patients with HER2-expressing DCIS. The vaccine helps the body recognize and attack cancer cells by targeting the HER2 protein. H2NVAC is a vaccine targeting the HER2 protein, similar to other HER2/neu vaccines being tested for their ability to elicit immune responses against breast cancer.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.